Bill117th CongressFiled Feb 4, 2021Health
H.R. 853
Closing Loopholes for Orphan Drugs Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Feb 4, 2021)
Closing Loopholes for Orphan Drugs Act
This bill revises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
What just happenedFeb 5, 2021
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Welch, Peter [D-VT-At Large](D-VT)Sponsor
1 cosponsor1 R
1cosponsors1committees4actions4subjects
- Introduced in HouseFeb 4, 2021
- Feb 5, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 4, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 4, 2021IntroReferralIntro-H
Introduced in House
- Feb 4, 2021IntroReferral1000
Introduced in House